Close Menu
    What's Hot

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026

    Editor’s Letter – Volume 2, Issue 8, August 2026

    August 12, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Annuity Sales Set New Quarterly Record in Second Quarter

      August 3, 2026

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    UK Pension Risk Transfer Market Sees Six Insurers Each Write Over £5bn for the First Time

    Longevity and Mortality Risk Transfer March 31, 2025By LMI Newsdesk
    Lane Clark & Peacock
    Share
    Twitter LinkedIn Email

    Analysis by Lane Clark & Peacock (LCP) shows that 2024 was another strong year for the UK pension risk transfer market, with a record-breaking 298 buy-ins / outs totalling £47.8bn plus £0.8bn of superfund transfers and £0.8bn of longevity swaps. 

    For the first time, six insurers wrote over £5bn each and, with Blumont’s entrance this month taking the market to a record 11 insurers, competition has reached its highest level.  

    LCP’s analysis is based on the insurers’ final reported results for 2024 and the key finding is that buy-in and buy-out volumes for 2024 were the second highest on record at £47.8bn, only just short of 2023’s record-breaking year of £49.1bn.  

    This was driven by a record number of large transactions with 14 buy-ins / outs over £1bn occurring in 2024, beating the previous record of 12 set in 2023. This included household names such as Compass, G4S, and TotalEnergies. 

    The largest deal, by far, was by the NatWest Group Pension Fund, which secured £9.6bn with Rothesay over two transactions in 2024 (£3.5bn in H1 and £6.1bn in H2). Together with £0.6bn with Rothesay in 2023,  NatWest has insured just over £10bn to date; the largest volume of any UK pension scheme and narrowly ahead of the previous record set by the ICI Pension Fund (£10.0bn to date). 

    Last year (2024) also saw a record-breaking number of transactions, with 298 completing in 2024, an increase of over 30% on last year’s number (2023: 227). The biggest growth segment was ‘micro’ sub-£10m schemes which saw a nearly 60% year-on-year increase in transaction numbers, making up over 30% of 2024 transactions. 

    More widely, smaller schemes of less than £100m made up nearly 80% of all transactions in 2024 (2023: c70%).  Nine out of 10 insurers completed transactions in this segment, with Just (120 transactions) and Aviva (52 transactions) completing the most under £100m. 

    Rothesay wrote the largest volumes in 2024 at £10.3bn (22% market share), driven by its deals with NatWest, followed by L&G on £8.4bn (18% market share) and PIC on £8.1bn (17% market share).  Aviva, Just and Standard Life also each wrote over £5bn of buy-ins / outs in 2024 (11%+ market shares).   

    Last year (2024)  was the most competitive year ever for the buy-in / out market. A record 10 insurers completed transactions, with six insurers writing over £5bn each (2023: five insurers). Brookfield announced in March that its new UK insurer, Blumont, had received regulatory approval and is now participating in transactions. Other recent new entrant insurers, M&G, Royal London and Utmost, continue to build their presence, writing £1.5bn between them in 2024.  

    The expansion of the superfund market is also offering schemes greater choice. The transfer in December by the Wates Pension Fund of its £210m scheme to Clara-Pensions was the first superfund transfer of a scheme with a non-distressed sponsor, opening the option to a wider range of schemes.   

    Longevity swaps are also seeing increased activity with BT Pension Scheme’s announcement recently of £10bn of hedging. This followed a quiet year in 2024 with only two longevity swaps totalling £0.8bn. 

    “The pension risk transfer market is firing on all cylinders, with record levels of competition and choice for schemes of all shapes and sizes. This can be seen by schemes such as NatWest which has completed over £10bn of buy-ins in the last 18 months, right down to the 60% year-on-year growth in transactions by ‘micro’ sub-£10m schemes,” said Charlie Finch, Partner at LCP. 

    “Transfers to Clara-Pensions last year have opened up superfunds as a viable option for a wider range of schemes.  And in coming months, the Government is due to publish further details on the shake-up of the rules around surplus release which should increase flexibility for schemes to run-on,” Finch added. 

    “Looking ahead, we’re seeing a continued focus from insurers with high levels of competition for transactions of all sizes.  It is particularly pleasing to see insurers responding to the rapid growth in demand for smaller schemes transactions, and new entrant insurers increasing competition for this market segment resulting in favourable pricing for well-run processes,” added Imogen Cothay, Partner at LCP.   

    “We’re also seeing continued innovation driving improvements in other aspects of insurers’ offerings, as pension schemes increasingly look to non-price factors such as the member experience to drive their insurer selection decisions.  Whilst larger schemes are leading the way, key innovations developed on the £1bn+ deals we led last year are now being made available to smaller schemes,” said Cothay. 

    2025 - March Longevity Risk News News: March 2025 Pension Risk Transfer
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

    August 13, 2026By LMI Newsdesk

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026By Greg Winterton

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.